www.fdanews.com/articles/184278-medtronic-receives-ce-mark-for-implantable-spinal-cord-stimulator
Medtronic Receives CE Mark for Implantable Spinal Cord Stimulator
November 7, 2017
Medtronic received the CE Mark for the Intellis platform for both spinal cord stimulation and peripheral nerve stimulation as an aid in the management of certain types of chronic pain.
The device can improve patient-physician communication by tracking and sharing daily activities, body positions and therapy usage and giving physicians an objective view of mobility and progress.
The device is managed on the Samsung Galaxy Tab S2 tablet interface and can record and track patient activity 24/7. It is now available in Europe and the United States.